Drägerwerk 9M 2026 EBIT rises 45% to EUR 111.8 million

By Public Technologies
  • Dräger’s nine-month 2026 EBIT rose 45% year-over-year to EUR 111.8 million, including EUR 27.9 million in customs refunds.
  • Third-quarter EBIT fell 15% year-over-year to EUR 48 million, while net sales increased to EUR 850.8 million.
  • For the first nine months, net sales rose year-over-year to EUR 2.45 billion.
  • Nine-month order intake increased year-over-year to EUR 2.67 billion, with Germany the largest growth driver.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drägerwerk AG & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2424128_en) on October 29, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk